Categories
Tags
Archives
-
Categories
- Animations
- Articles
- Awards
- Blogs
- Case studies
- Events
- Guides
- Infographics
- News
- Testimonials
- Videos
- Webinars
- White papers
- Sign up for latest news
- Send us an email
- Call +44 (0)20 8069 5000
-
London
Chester House
81-83 Fulham High Street
London, SW6 3JW
Tel: +44 (0)20 8069 5000
Fax: +44 (0)845 544 2095
View Map -
Lyon
4 Place Amédée Bonnet
69002 Lyon
Tel: +33 6849 41803
Fax:
View Map -
Singapore
94 Club Street
Singapore, 069462
Tel: +65 6222 4646
Fax: +65 6327 9636
View Map -
New York
19 West 21st Street, Suite 703
New York, NY 10010
Tel: +1 646 798 4744
Fax:
View Map -
Philadelphia
1155 Business Center Drive
Suite 130
Horsham, PA 19044
Tel: +1 215 682 9200
Fax: +1 215 682 9205
View Map -
San Francisco
466 Geary St Suite 200
San Francisco, CA 94102
Tel: +1 415 818 8140
Fax:
View Map
-
Tags
- Emerging Markets
- Healthcare Market Research
- Therapy Watch
- Patient Research
- Living With
- Asia
- China
- Events
- Living With A Chronic Illness
- Quantitative
- Market Access
- Case Study
- Ephmra
- Webinar
- COVID19
- Qualitative Research
- Oncology
- Pricing
- APAC
- Quantitative Research
- Video
- Careers
- Coronavirus
- Rheumatoid Arthritis
- Client Feedback
- Forever Angels
- Testimonial
- Conference Live
- Digital
- Patient Journey
- Vaccines
- Conference Research
- PMRC
- Appointments
- Singapore
- USA
- Graduates
- Rare Diseases
- Conference
- LATAM
- Biosimilars
- Latin America
- Medtech
- Patient Centricity
- Patients
- Quant
- Innovation
- Mariel Metcalfe
- Pharmaceuticals
- US
- Asia-Pacific
- Biologic
- Diabetes
- Digital Health
- Facial Analysis
- Infographics
- Mobile Research
- Portfolio Analysis
- Richard Head
- Segmentation
- ASEAN
- BHBIA
- Chronic Disease
- Global Health
- HCV
- Laurent Chanroux
- RA
- Storytelling
- Brazil
- HIV
- Market Research
- Nutrition
- PBIRG
- Psoriasis
- Research Partnership
- US Offices
- Anniversary
- Asthma
- Brand Tracking
- Charity
- Data Visualisation
- Demand Assessment
- Europe
- Event
- Intellus
- New Starter
- News
- Philadelphia
- Rheumatology
- Therapy Watch RA
- UX
- AI
- Allison Fleetwood
- Asia Pacific
- Blog
- BRIC
- Devices
- Female Health
- Graduate Programme
- Harriet Kozak
- Infographic
- ISPOR
- Japan
- John Branston
- Lizapliss
- Lupus Study
- MENA
- Mexico
- New Appointments
- Nutraceuticals
- Outputs
- Payers
- Pharma Market Research Conference
- PSP
- Sue Rees
- Tracking
- Access Partnership
- Agile Research
- Angela Duffy
- Ankylosing Spondylitis
- Artificial Intelligence
- Awards
- Behavioural
- Behavioural Economics
- CEE
- Claire Richardson
- Community Day
- Conjoint
- Crohn’S Disease
- Darren Kottler
- Digital Research
- Experience
- Healthcare
- Immuno-Oncology
- Immunotherapy
- India
- Marc Yates
- NASH
- New Jersey
- Nr-Axial Spa
- Patient Power
- Promotion
- Real World Evidence
- Rheumatologists
- Rheumatology Event
- Strategy
- The Studio
- Therapy Watch HCV
- Userexperience
- UX Research
- Uxresearch
- Vaccine
- Virtual Conference
- Virtual Reality
- Whitepaper
- Women's Health
- Advanced Analytics
- Africa
- Atopicdermatitis
- Augmented Reality
- Biologic Treatment
- BOBI Award
- Cardiovascular
- Choicequal
- Communication
- Depression
- EMEA
- EULAR
- Eyeforpharma
- Free Thinking
- Guide
- Haematology
- Healthcare News
- Helen Parfitt
- Janssen
- League Tables
- Mental Health
- Middle East
- MRS
- Paul Reed
- Payer Research
- Pharmaceutical Market Research
- Physicians
- PMRG
- Publication Research
- Rare Disease
- Reimbursement
- Rob White
- Rx Rationale
- Social Media
- South Korea
- Technology
- Webcast
- 2018 Intake
- Access
- Anaemia In CKD
- Analytics
- Animation
- Annual Conference 2018
- Apprentices
- Arthritis
- ATU
- Autoimmune
- Basel
- Behavioural Science
- Big Data
- Biologics
- Biosimilars Market Share
- Bulletin Boards
- Caribbean
- Case Studies
- Christmas
- CML
- Colombia
- Compliance
- Complimentary Guide
- Congress
- COVID
- COVID-19
- Creative Services
- Deliverables
- Dermatologists
- Dermatology
- Developing Countries
- Device Testing
- Ebola
- Emerging Market
- Emotional Analysis
- Ethnography Research
- Expertise
- Forecasting
- Fundraising
- Gastroenterologists
- Gastroenterology
- Health Economics
- Healthcare Expertise
- Healthcare In China
- Healthcare Reform
- HEOR
- Hepatitis C Treatments
- Hepatitis Patients
- Holidays
- Korea
- Linked Modelling
- Lunar New Year
- Migraine
- MINT
- MRX
- Online Community
- Outcomes Research
- Patient Compliance
- Patient Support
- Patient Support Programmes
- Patient Tracking Tool
- Patient Treatment Programmes
- PBIRG Winter Workshops
- Pei Li Teh
- Pei-Li Teh
- Pharma Market Research
- Pharma News
- Physicians’ Perceptions
- Pricing Research
- Pso Patients
- PSP Enhance
- Publication
- Published Research
- RA Patients
- Russia
- San Francisco
- Saudi Arabia
- Self-Pay
- Severe Asthma
- Social Listening
- South Africa
- South America
- Syndicated Research
- Taiwan
- Telehealth
- Telemedicine
- Tom Winter
- UK Office
- Ulcerative Colitis
- White Paper
- Willingness To Pay
- Zika
- 15 Years
- 2017 Intake
- AAD Conference
- ACA
- Acne
- Adherence
- Admin
- Advisory Boards
- Aesthetics
- Ageing
- Ahmed Edathodu
- Allergy
- AMEA
- AMLO
- Anaemia
- Analysis
- Analytical Techniques
- Anna March Garcia
- Anna Spivack
- Anne Cunningham
- Annual Report
- Annualreport
- Anthony Greenwood
- Anxiety
- Apprenticeships
- Argentina
- Around-The-Pill
- ASCO
- Atopic Dermatitis
- Attitudinal
- Axial Spondyloarthritis
- Backroom Brainstorm
- Bangkok
- Behaviour
- Behaviour Science
- Best Business Impact
- Best Practice
- Beyond The Pill
- Biologic Patient
- Biomarker
- Biosimilars Prescribing Data
- Birgit Eschmann
- Blood Cancer
- Blood Glucose Monitoring
- Buying
- Calibration
- Cancer
- Chile
- Cholesterol
- Christelle Malingrey
- Christine Naegle
- CKD
- Clinical Trails
- Communication Strategy
- Conferences
- Congress Research
- Corona
- Cosentyx
- Cosmetics
- Counterfiets
- COVD19
- Dan Coffin
- Demand
- Design
- Diagnostics
- Digital Methodologies
- Digital Patient
- Digital Services
- Director
- Dr Shrinivas Rao Mukku
- Drug Approval
- Duncan Munro
- Düsseldorf
- EADV Valencia 2015
- Eczema
- Emergency Care
- Emotional Response
- Eosinophilic Asthma
- Ephmra Asia
- Ephmra Awards
- Epidemiological Data Review
- ESC
- ESOMAR
- EU
- European Pso Market
- Facial Recognition
- Food
- France
- Fulham Green
- Gamification
- Gene
- Genome
- Giving
- Global Healthcare
- Global Reach
- Global Tracking
- Gulf
- Halal
- Harrison Gaiger
- Healthcare Environment
- Healthcare Market Researc
- Helenparfitt
- Hepatitis
- Hepatitis Price War
- Hidradenitis Suppurativa
- Hong Kong
- Hospital Care
- How To Play
- How To Win
- HPV
- Hyperlipidemia
- IBS
- Immersive Research
- Immersive Technologies
- Immunisation
- Impact
- Indonesia
- Influenza
- INSABI
- Integration Modelling
- Interactive Infographic
- Intollerance
- Iole Beattie
- Jack Layhurst Awards
- Jordan Thomas
- Katie Watts
- Kenya
- Kevin Mayo
- Key Driver Analysis
- KPI Tracking
- LATC
- Lung Cancer
- Marianne Jaeger
- Mark Jeffery
- Market Landscape
- Market Research Society
- Medical Devices
- Medical Journal
- Medical Records
- Medical Tourism
- Melanoma
- Melinda Shorr
- Mental Illness
- Mike Mallinson
- Mobile
- Mobile Conference Research
- Mobile Evaluation
- Mohan Vicneswararajah
- Molecular Testing
- Multiple Myeloma
- Neurology
- Neuroscience
- New Office
- New Product Development
- New York
- Nicky Barclay-Prout
- Nigeria
- Non-Radiographic Axial Spondyloarthritis
- North Africa
- North Asia
- Novel Therapies
- NSCLC
- Observational Research
- Office Opening
- Online Awareness Campaign
- Online Communities
- Online Research
- Opportunity
- Opportunity Assessment
- Originator Biologics
- Orphan Disease
- Orphan Diseases
- Otezla
- Paediatrics
- Pandemics
- Pascal King
- Patient Centric
- Patient Psoriasis Data
- Patient Record Data
- Patient Research In Asia
- Patient Research In Psoriasis
- Patient Support Prograames
- Patient Tracking
- Patient Willingness To Pay
- Patient-Centricity
- Payer
- PCSK9
- PD1
- PDL1
- Pharma Economics
- Pharma Exec
- Pharma Market Tracking
- Pharmacoeconomics
- Pharmacy
- Phil Rosenberg
- PME
- PMRC Europe
- Praluent
- Predictions
- Preventative Health
- Probiotics
- Product Launch
- Product Opportunity
- Product Portfolio
- Projective Techniques
- Promotions
- Prostate Cancer
- Prostate Cancer Patients
- Psa
- Psoriasis Market
- Psoriatic Arthritis
- Psychological Impact
- Published
- QRCA
- Qualitative
- Quirk's
- Raquelnunez
- Real World Data
- Reflection
- Repatha
- Research
- Respiratory Disease
- Rheumatoid Arthritis Patients
- Rosacea
- Sarscov2
- SCCHN
- Scientific Publication
- Scientific Publication
- Screening
- Seguro Popular
- Seminar
- Sequencing
- Severe & Eosinophilic Asthma
- Simalto
- Simponi
- Social Analytics
- Social Monitoring
- South East Asia
- Sovaldi
- Spinraza
- Spondyloarthritis
- Stakeholders
- Statistical Modeling
- Summer Day Out
- Support Programmes
- Survey
- Syndicated Tracking Study
- Tanzania
- Techniques
- Thalia Nikoglou
- Therapy Watch HBV
- Therapy Watch HIV
- Therapy Watch IBD
- Therapy Watch LATAM
- Therapy Watch Prostate Cancer
- Therapy Watch Psa
- Therapy Watch Pso
- Therapy Watch UC
- Thestudio
- THET
- Tokyo
- Training
- Tropical Diseases
- Turkey
- US Community Day
- US Healthcare
- User Experience
- Vaccination
- Venezuela
- Vicky Mclellan
- Virtual Conference Live
- Virtual Conference Research
- Vitiligo
- VR/AR
- Working
- World Health
- Zoom
- see more see less »
-
Archives
- December 2008
- August 2008
- May 2008
- September 2008
- July 2009
- March 2009
- October 2009
- September 2009
- April 2009
- October 2010
- September 2010
- August 2010
- June 2010
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2013
- December 2013
- January 2014
- February 2014
- March 2014
- April 2014
- May 2014
- June 2014
- July 2014
- August 2014
- September 2014
- October 2014
- November 2014
- December 2014
- January 2015
- February 2015
- March 2015
- April 2015
- May 2015
- June 2015
- July 2015
- August 2015
- September 2015
- October 2015
- November 2015
- December 2015
- January 2016
- February 2016
- March 2016
- April 2016
- May 2016
- June 2016
- July 2016
- August 2016
- September 2016
- October 2016
- November 2016
- December 2016
- January 2017
- February 2017
- March 2017
- April 2017
- May 2017
- June 2017
- July 2017
- August 2017
- September 2017
- October 2017
- November 2017
- December 2017
- January 2018
- February 2018
- March 2018
- April 2018
- May 2018
- June 2018
- July 2018
- August 2018
- September 2018
- October 2018
- November 2018
- December 2018
- January 2019
- February 2019
- March 2019
- April 2019
- May 2019
- June 2019
- July 2019
- August 2019
- September 2019
- October 2019
- November 2019
- December 2019
- January 2020
- February 2020
- March 2020
- April 2020
- May 2020
- June 2020
- July 2020
- August 2020
- September 2020
- October 2020
- November 2020
- January 2021
- see more see less »
- Posted by Katrina Johnson
- December 16, 2014
- Webinars
The patient journey: Time to look beyond the physician?

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.
However a recent study demonstrated that physicians spend as little as 49 seconds in dealing with a new treatment initiation with their patients.
So it is no surprise that more and more pharma marketers are steadily looking beyond the physician in order to improve patient engagement.
In this webinar Director Katrina Johnson and Associate Director Kate Hanson explore the ways that patient journey research can aid development of an effective "beyond the pill" strategy, leading to greater patient engagement and improved treatment outcomes.
- Posted by Paul Reed
- November 20, 2014
- Articles
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

Published in eyeforpharma 10 November by Paul Reed
In 2009 the Brazilian government passed the Generics Drugs Act; one of numerous initiatives intended to reduce spend on originator branded drugs, whilst boosting generic drug prescription and supporting the domestic drug industry.
5 years on from the act, how successful have the Brazilian government been in advancing the local pharmaceutical players while reducing branded originator drugs spend? And importantly, is there still an opportunity for branded originator drugs?
- Posted by Darren Kottler
- November 11, 2014
- Articles
Exploring HCV in Brazil

Brazil has developed a strong commitment to universal access to healthcare and now promotes a “health for all” vision that is providing more advanced treatments to a whole new class of patient.
This has caused the healthcare challenges to shift from a lack of availability, to discussions about willingness to spend limited resources and effective allocation of treatment. All of which has led to Brazil becoming one of the world’s largest pharma markets.
- Posted by Julie Denny
- November 11, 2014
- Articles
The American College of Rheumatology 2014 Annual Meeting

Join us at ACR’s 2014 Annual Meeting in Boston on November 18th
We are delighted to be presenting a poster at the American College of Rheumatology’s 2014 Annual Meeting, which is set to take place in Boston, 14th to 19th November. It is a key meeting in the field of rheumatology providing physicians with a wide range of educational programs in every area of the field, including our poster presentation on "Early Treatment in Rheumatoid Arthritis and Its Effect on Patient Outcomes".
- Posted by Laurent Chanroux
- November 11, 2014
- Articles
Physicians predict the impact new molecules will have on the EU psoriasis market

With several new molecules expected to launch onto the psoriasis market over the next 12 months, we recently asked our panel of 200 EU-based dermatologists the impact this may have on their future prescribing behaviour.
Utilising our panel of 200 EU based dermatologists, our results reveal that 74% of physicians are aware of new classes and/or drugs in development for the treatment of Psoriasis (PsO) without prompting. IL-17 inhibitors were the most commonly mentioned drugs cited by 75% of respondents, followed by JAK-inhibitors and PDE-inhibitors. However, when physicians were prompted about their familiarity with key pipeline agents they reported low scores overall, suggesting that more awareness and improvement of physicians’ knowledge of these late stage compounds are needed to achieve growth in the market.